Efficacy and safety of hetrombopag in the treatment of chemotherapy-related thrombocytopenia in solid tumors: a retrospective study

ObjectiveThis study aims to evaluate the efficacy and safety of hetrombopag in the management of chemotherapy-induced thrombocytopenia (CIT) among patients with solid tumors, utilizing a retrospective cohort study design.MethodsThe study population comprised patients experiencing CIT due to chemothe...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Yuan Yuan, Qiang Tong, Jia-hui Liu, Ye Kang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-10-01
Subjects:	hetrombopag solid tumors thrombopoietin-receptor agonist (TPO-RA) chemotherapy-induced thrombocytopenia (CIT) recombinant human thrombopoietin (rhTPO)
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1670029/full